Category: Metabolic

This category is for metabolic related peptides.

Tesamorelin

Tesamorelin: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

Tesamorelin is a synthetic peptide medication that stimulates the body’s own release of growth hormone, or GH, by mimicking natural growth hormone-releasing hormone, or GHRH. It is particularly interesting because, unlike many peptides discussed in research and wellness settings, tesamorelin is an FDA-approved prescription medication. In the United States, tesamorelin is marketed as EGRIFTA WR® […]

Continue Reading
Semaglutide

Semaglutide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

Semaglutide is a peptide-based medication that has become one of the most important drugs in modern diabetes, obesity, and cardiovascular medicine. It belongs to a class known as GLP-1 receptor agonists, meaning it mimics the activity of the naturally occurring hormone glucagon-like peptide-1, or GLP-1. GLP-1 is released from the gastrointestinal tract after eating and […]

Continue Reading
KLOW peptide

KLOW Peptide Blend: A Comprehensive Guide to Components, Uses, Research, Dosing Information, Forms, and Potential Benefits

Peptide Gold0

KLOW peptide is a multi-peptide research blend that has attracted increasing attention because it combines four compounds associated with inflammation, tissue repair, collagen remodeling, wound healing, gastrointestinal biology, skin health, and connective-tissue recovery. KLOW peptide is not a single peptide. Instead, the name generally refers to a combination of: KPV GHK-Cu BPC-157 and TB-500. The […]

Continue Reading

Tirzepatide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

Tirzepatide is one of the most important medications to emerge in modern metabolic medicine. It is a once-weekly injectable peptide-based medication that activates two hormone receptors involved in blood sugar control, appetite, and body weight: GIP — glucose-dependent insulinotropic polypeptide and GLP-1 — glucagon-like peptide-1. Because it targets both receptors simultaneously, tirzepatide is commonly described […]

Continue Reading

Cagrilintide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

Cagrilintide peptide is one of the more interesting investigational peptides currently being developed for obesity, appetite regulation, weight management, and metabolic health. Unlike semaglutide, tirzepatide, and retatrutide, cagrilintide peptide is not primarily a GLP-1-based compound. Instead, it is a long-acting amylin analogue, meaning it is designed to mimic and enhance some of the biological effects […]

Continue Reading

AOD-9604: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

AOD-9604 is an experimental peptide that has attracted attention for more than two decades because of its potential effects on fat metabolism, lipolysis, body composition, and obesity research. Unlike many newer metabolic peptides that act through GLP-1, GIP, or glucagon receptors, AOD-9604 originated from research involving human growth hormone, or hGH. Scientists were interested in […]

Continue Reading

5-Amino-1MQ: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

Among the growing number of experimental compounds being investigated for metabolism, body composition, and healthy aging, 5-Amino-1MQ has generated considerable interest. Often discussed alongside research peptides, 5-Amino-1MQ is associated primarily with research involving fat metabolism, obesity, cellular energy, NAD+ biology, and metabolic health. Its mechanism is very different from familiar metabolic compounds such as semaglutide, […]

Continue Reading
retatrutide peptide

Retatrutide: A Comprehensive Guide to Uses, Research, Dosing, Forms, and Potential Benefits

Peptide Gold0

Few experimental metabolic peptides have generated as much attention as retatrutide peptide. Developed by Eli Lilly and Company under the research designation LY3437943, retatrutide is being investigated primarily for obesity and related metabolic conditions. The excitement surrounding retatrutide peptide comes from its unusual mechanism of action. While semaglutide targets the GLP-1 receptor and tirzepatide targets […]

Continue Reading